SHALBY
|
|
BOM : 540797 NSE : SHALBY | |
LT :
Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : None or < 25% |
Apr 04,2025 |
Price(EOD): ₹ 199.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 2,152.98 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
SHALBY | 0.6% | 6.5% | -14.5% |
MAX HEALTHCARE INSTITUTE | 3.5% | 14.9% | 36.6% |
APOLLO HOSPITALS ENTERPRISE | 1.5% | 8.6% | 3.9% |
FORTIS HEALTHCARE | -7.1% | 1.4% | 54.2% |
GLOBAL HEALTH | 2.9% | 2% | -7.4% |
NARAYANA HRUDAYALAYA | -0.8% | 7.9% | 28.7% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -7.2% | 15.7% | 45.9% |
DR LAL PATHLABS | 1.5% | 5.3% | 10.5% |
ASTER DM HEALTHCARE | -0.5% | 21.9% | 18.8% |
FUNDAMENTAL ANALYSIS OF SHALBY
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SHALBY
Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
71.42
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 30.15 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 2.15
P/B Calculated based on Book Value of Rs 999.56 Cr
[Latest Year - Mar2024 - Consolidated Results ] 2.02
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,066.30 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
23% -1% -34% |
SHARE PRICE MOMENTUM OF SHALBY
SHALBY vs SENSEX
DEBT OF SHALBY
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.11 0.03 0.05 0.06 |
0.31 0.15 0.18 0.21 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SHALBY
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SHALBY
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.03% 3.86% -9.88% -226.82% |
27.58% -19.89% -59.92% -115.7% |
QtrlyTrend |
-2 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
SHALBY related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | NA | 7% | 4.8% |
BSE SMALLCAP | -2% | 7.2% | 3.2% |
BSE HEALTHCARE | -2.3% | 5.7% | 14.3% |
BSE MIDSMALLCAP | -2.6% | 6% | 2.3% |
You may also like the below Video Courses
FAQ about SHALBY
Is SHALBY good for long term investment?
As on Apr 04,2025, the Fundamentals of SHALBY look Strong and hence it may be good for long term investment! See Financial Performance of SHALBY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SHALBY UnderValued or OverValued?
As on Apr 04,2025, SHALBY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SHALBY ?
As on Apr 04,2025, the Intrinsic Value of SHALBY is Rs. 200.38 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 162.46
Fair Value [Median EV / Sales Model] : Rs. 200.38
Fair Value [Median Price / Sales Model] : Rs. 299.78
Estimated Median Fair Value of SHALBY : Rs. 200.38
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.